AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) sold $50K-$100K of Bristol-Myers Squibb Company (BMY) stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of Bristol-Myers Squibb Company (BMY) stock worth $50K-$100K in a STOCK Act filing on Jun 20, 2018.
The trade happened on Jun 4, 2018, 16 days before it was made public.
BMY has moved +18.9% since the trade date, from $51.45 to $61.15 (Oct 2, 2026 close).
- Traded
- Jun 4, 2018
- Disclosed
- Jun 20, 2018
- Filing delay
- 16 days
- Price since
- +18.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (2)
More BMY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.